Mia's Feed
Medical News & Research

Endolymphatic Sac Decompression Shows Promise in Treating Vertigo and Migraine in Meniere's Disease Patients

Endolymphatic Sac Decompression Shows Promise in Treating Vertigo and Migraine in Meniere's Disease Patients

Share this article

Endolymphatic sac decompression (ELSD) has shown promising results in relieving vertigo and migraines in patients with Meniere's disease, with the potential for shared underlying mechanisms between these symptoms. Recent research highlights its effectiveness, especially in patients without hypertension.

2 min read

A recent study published in Acta Oto-Laryngologica highlights the effectiveness of endolymphatic sac decompression (ELSD) in alleviating symptoms of vertigo and migraine for patients suffering from Meniere's disease (MD), especially those with accompanying migraines. The study, conducted by researchers including Lin Han from Peking University, involved 104 MD patients and aimed to understand the connection between MD and migraine, as well as the impact of ELSD on symptom relief.

Patients were monitored for their frequency of vertigo episodes and migraine severity before and after undergoing ELSD. The results showed that nearly half of the patients with MD alone experienced vertigo relief post-surgery, with a relief rate of 46.7%. Patients with MD and migraine had a slightly lower relief rate of 40.68%, but both groups demonstrated significant reductions in monthly vertigo episodes and migraine severity. The correlation between vertigo and migraine outcomes was moderate, suggesting some shared underlying mechanisms.

Interestingly, the study identified that the absence of hypertension was a predictor of better relief, and male gender independently predicted migraine improvement. The findings support the hypothesis that vertigo and migraines may share common inflammatory pathways, contributing to their co-occurrence in MD patients.

Overall, ELSD appears to be a promising surgical intervention for symptom relief in MD patients, particularly those suffering from both vertigo and migraines. The study underscores the importance of personalized treatment plans and further research to better understand the shared pathophysiology of these conditions.

More details and the full study can be accessed through the DOI: 10.1080/00016489.2025.2491651.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

How APOL1 Mutations Impact Mitochondrial Function in Kidney Disease Revealed by Organoid Models

New research using kidney organoids uncovers how APOL1 gene mutations impair mitochondrial function, shedding light on mechanisms behind genetic kidney disease and opening doors for targeted therapies.

Rising Ketamine-Related Deaths in the UK Highlight Polydrug Risks and Need for Comprehensive Harm Reduction

Analysis uncovers a twentyfold increase in ketamine-related deaths in the UK since 2015, highlighting complex drug use patterns and the urgent need for comprehensive harm reduction strategies.

Innovative Multi-Layer Drilling Plate Enhances Preclinical Dental Training

A new multi-layer drilling plate designed to replicate natural dental tissues promises to improve realism in preclinical dental training, offering a more effective educational tool for students worldwide.

Innovative AI-Based Rapid Testing for Viral Infections

A new AI-driven nanopore test enables quick and accurate detection of live viruses within minutes, promising to enhance viral infection diagnosis and treatment.